How do women suffering from multiple chemical sensitivity experience the medical encounter? a qualitative study in Spain.
Briones-Vozmediano, Erica, Espinar-Ruiz, Eva · Disability and rehabilitation · 2021 · DOI
Quick Summary
This study interviewed 22 Spanish women with Multiple Chemical Sensitivity (MCS) to understand their experiences with doctors and the healthcare system. The women reported two major problems: they cannot avoid exposure to chemicals in their environment, and they struggle to find effective treatment. Many also felt that healthcare providers didn't believe their illness was real or took their symptoms seriously.
Why It Matters
Although this study focuses on MCS, it directly parallels ME/CFS as both are classified as contested illnesses where patients face widespread medical skepticism and diagnostic delays. The findings highlight systemic barriers to recognition that ME/CFS patients also experience, and recommendations for healthcare provider training and protocol development are equally applicable to improving care for ME/CFS patients.
Observed Findings
Healthcare providers frequently expressed skepticism about MCS diagnosis and existence, hindering patient recognition and follow-up care.
Patients reported unavoidable chemical exposure in their daily environments and inability to access effective treatments.
Women experienced stigmatization when healthcare providers attributed their symptoms to psychological causes rather than organic illness.
Diagnostic processes were prolonged and complicated by lack of professional awareness about MCS.
Patients reported that provider rejection and delegitimization added significant negative emotional burden to their physical suffering.
Inferred Conclusions
Provider prejudices regarding contested illness status directly obstruct timely diagnosis and appropriate medical management for MCS patients.
Systematic healthcare provider training addressing both knowledge and awareness about MCS is necessary to improve care quality.
Protocols specifically designed for MCS management, including chemical avoidance strategies within healthcare facilities, should be developed and implemented.
Avoidance of psychologization and recognition of stereotypes about women with MCS are critical to reducing iatrogenic harm.
Remaining Questions
What This Study Does Not Prove
This qualitative study does not establish the biological mechanisms underlying MCS or prove causation between chemical exposure and symptom development. It describes patient experiences rather than objectively measuring disease severity, exposure levels, or treatment outcomes. The findings reflect Spanish healthcare contexts and may not generalize to other regions or healthcare systems.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →